WCG Blog

Insights from the WIRB-Copernicus Group

Post-approval Pharmacovigilance: Support Along the Entire Lifecycle of Your Drug
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Five Tips for Improving Your Site's Study Start-Up Timelines
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Download Report
A Successful DMC Requires a Productive, Early Organizational Meeting
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Five Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
What Are Clinical Trials and How Do They Benefit Participants?
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Improve Training, Increase Participation, Reduce Redundancy, & Cut Costs: Why Virtual Site Training is the New Norm
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
×

Email

Email

First Name

Last Name

Company

Thank you!

Error - something went wrong!
New Study Uncovers the $966 Billion Economic Impact of Rare Diseases
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Best Practices for Research Sites: Effectively Using Patient Recruitment Advertising Dollars
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Data and Biorepository Management During a Pandemic
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Informed Consent: An IRB Perspective on Navigating the New Normal
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
New Normal or Not, Safety Reporting Matters
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
There is Value to Patients When Independent Sites Offer Clinical Trials
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
COVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Four Tips For Navigating Patient Recruitment During COVID-19
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
WCG: Advocating for Patients in a time of COVID-19
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
COVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD

The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
COVID-19 Preparedness for Health Care Institutions with Dr. Paul Biddinger of Massachusetts General Hospital
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Essential Considerations for CTMS Integrations and Data Migrations
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
NIH Launches NExTRAC to Advise on Emerging Biotechnologies
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Be the Site of Choice

In early October, over hundreds of representatives of clinical research sites and members from biopharmaceutical companies came together for WCG’s Global Research Network™ Be the Site of Choice Event.
- Facebook
- Twitter
- Email
- LinkedIn
Read Post
Loading More...

WCG Blog

Post-approval Pharmacovigilance: Support Along the Entire Lifecycle of Your Drug

Five Tips for Improving Your Site's Study Start-Up Timelines

A Successful DMC Requires a Productive, Early Organizational Meeting

Five Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site

What Are Clinical Trials and How Do They Benefit Participants?

Improve Training, Increase Participation, Reduce Redundancy, & Cut Costs: Why Virtual Site Training is the New Norm

New Study Uncovers the $966 Billion Economic Impact of Rare Diseases

Best Practices for Research Sites: Effectively Using Patient Recruitment Advertising Dollars

Data and Biorepository Management During a Pandemic

Informed Consent: An IRB Perspective on Navigating the New Normal

New Normal or Not, Safety Reporting Matters

There is Value to Patients When Independent Sites Offer Clinical Trials

COVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up

Four Tips For Navigating Patient Recruitment During COVID-19

WCG: Advocating for Patients in a time of COVID-19

COVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD

The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.

COVID-19 Preparedness for Health Care Institutions with Dr. Paul Biddinger of Massachusetts General Hospital

Essential Considerations for CTMS Integrations and Data Migrations

NIH Launches NExTRAC to Advise on Emerging Biotechnologies

Be the Site of Choice

In early October, over hundreds of representatives of clinical research sites and members from biopharmaceutical companies came together for WCG’s Global Research Network™ Be the Site of Choice Event.